Hannah Brendan
Insider CIK 1929422 · CRTX Chief Business Officer and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2026-01-23 | 2026-01-23 | 365,000 | — | $0 | 365,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | M Exercise deriv | 2025-12-05 | 2025-12-08 | 2,271 | — | $0 | 45,168 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | M Exercise deriv | 2025-12-05 | 2025-12-08 | 25,280 | — | $0 | 199,720 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | M Exercise | 2025-12-05 | 2025-12-08 | 2,271 | $0.55 | $1.2K | 336,547 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | M Exercise | 2025-12-05 | 2025-12-08 | 25,280 | $0.94 | $23.8K | 361,827 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-23 | 37,736 | $0.13 | $4.9K | 37,736 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award | 2025-06-18 | 2025-06-23 | 37,736 | $1.20 | $45.3K | 334,276 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-01-28 | 2025-02-11 | 450,000 | — | $0 | 450,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2024-08-21 | 2024-08-21 | 5,000 | $0.62 | $3.1K | 272,975 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2024-08-21 | 2024-08-21 | 2,280 | $0.61 | $1.4K | 267,975 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2024-08-21 | 2024-08-21 | 23,565 | $0.63 | $14.8K | 296,540 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2024-08-20 | 2024-08-21 | 3,424 | $0.60 | $2.1K | 265,695 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2024-08-20 | 2024-08-21 | 2,500 | $0.61 | $1.5K | 262,271 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2024-08-19 | 2024-08-21 | 2,155 | $0.58 | $1.2K | 259,771 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | M Exercise deriv | 2024-06-04 | 2024-06-05 | 56,061 | — | $0 | 47,439 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | M Exercise | 2024-06-04 | 2024-06-05 | 56,061 | $0.55 | $30.8K | 257,616 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-02 | 600,000 | — | $0 | 600,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2023-10-24 | 2023-10-26 | 75,000 | — | $0 | 75,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2023-08-08 | 2023-08-09 | 71,762 | $1.22 | $87.5K | 201,555 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2022-05-23 | 2022-05-23 | 353,656 | — | $0 | 353,656 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2022-05-19 | 2022-05-23 | 103,500 | — | $0 | 103,500 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award | 2022-05-19 | 2022-05-23 | 16,224 | — | $0 | 16,224 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award | 2022-05-19 | 2022-05-27 | 113,569 | — | $0 | 129,793 | SEC↗ |